Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

AIDS pill's price tag draws criticism

Editor's pick
San Francisco Chronicle
24 August 2012
New & experimental hepatitis C treatment

Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C

Editor's pick
Bristol Myers Squibb press release
24 August 2012
Changing treatment

Are antiretroviral switch or simplification studies of benefit for patients?

News
15 August 2012
Access to healthcare

AIDS Sufferers Seen Hurt in Pacific Trade Pact Limits

Editor's pick
Business Week
9 August 2012
Pharmaceutical industry

Bristol-Myers Halts Hepatitis C Trial as Pipeline Stumbles - OregonLive.com

Editor's pick
Oreegonlive.com
8 August 2012
New & experimental hepatitis C treatment

Achillon hep C drug shows promise in mid-stage study

Editor's pick
Reuters
8 August 2012
Pharmaceutical industry

Bristol-Myers Squibb executive arrested on insider trading charges

Editor's pick
hepatitiscnewdrugs.blogspot.com
3 August 2012
Pharmaceutical industry

Gilead Sciences Announces New Collaboration with Indian Partners to Reduce Manufacturing Cost and Improve Availability of Emtricitabine-Based Antiretroviral Therapy in Developing Countries

Editor's pick
Bloomberg Business Week
2 August 2012
New & experimental hepatitis C treatment

Like Gilead, Achillion Should Trade Up On Bad News For Bristol-Myers, Idenix

Editor's pick
Reuters
2 August 2012
Adherence

Digital pills make their way to market

Editor's pick
Nature
2 August 2012
New & experimental hepatitis C treatment

Gilead Begins Single Pill Hepatitis C Study for 2014 Approval

Editor's pick
Businessweek
29 July 2012
Finance & funding

First generic HIV drugs could save US at least $920 million a year

News
27 July 2012
Access to healthcare

United States trade policy undermines access to anti-retroviral medicines

Editor's pick
Oxfam
25 July 2012
New & experimental HIV treatments

Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV

Editor's pick
Merck press release
24 July 2012
Pharmaceutical industry

Thailand Urged To Reject Gilead AIDS Drug Patents

Editor's pick
Pharmalot
23 July 2012
HIV treatment for children & young people

DNDi and Cipla to Develop 4-in-1 Paediatric Antiretroviral Drug Combination

Editor's pick
DNDi
20 July 2012
HIV treatment for children & young people

ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment

Editor's pick
Viiv Healthcare press release
18 July 2012
PrEP

Gilead Wins US Approval for First HIV Prevention Pill

Editor's pick
Bloomberg BusinessWeek
17 July 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV

Editor's pick
Market Watch (press release)
11 July 2012
Access to healthcare

India Weighs Providing Free Drugs at State-Run Hospitals

Editor's pick
New York Times
6 July 2012
Types of HIV tests

OraSure Rises to Highest Price Since 2005 on HIV Test

Editor's pick
Businessweek
6 July 2012
HIV treatment

Next Front in Worldwide AIDS Battle: Stretching Use of Anti-HIV Drugs

Editor's pick
Newswise (press release)
6 July 2012
Pharmaceutical industry

How Secrecy in Medical Research Harms our Health

Editor's pick
Open Society Foundations
5 July 2012
Pharmaceutical industry

EU Parliament Rejects ACTA; Allowing for Continued Access to Generic Medicines in Developing Countries

Editor's pick
MSF
4 July 2012